Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AtriCure (ATRC) Operating Expenses (2016 - 2025)

AtriCure (ATRC) has disclosed Operating Expenses for 16 consecutive years, with $102.8 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses fell 4.01% to $102.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $410.2 million through Dec 2025, up 5.85% year-over-year, with the annual reading at $410.2 million for FY2025, 5.85% up from the prior year.
  • Operating Expenses for Q4 2025 was $102.8 million at AtriCure, up from $101.1 million in the prior quarter.
  • The five-year high for Operating Expenses was $107.7 million in Q2 2025, with the low at -$46.4 million in Q3 2021.
  • Average Operating Expenses over 5 years is $78.2 million, with a median of $81.6 million recorded in 2023.
  • The sharpest move saw Operating Expenses tumbled 204.78% in 2021, then surged 255.97% in 2022.
  • Over 5 years, Operating Expenses stood at $67.5 million in 2021, then rose by 2.56% to $69.2 million in 2022, then grew by 27.78% to $88.5 million in 2023, then grew by 21.09% to $107.1 million in 2024, then fell by 4.01% to $102.8 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $102.8 million, $101.1 million, and $107.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.